ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

5.22
0.26
(5.24%)
Closed 23 November 8:00AM
5.22
0.00
( 0.00% )
Pre Market: 11:54PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.22
Bid
4.91
Offer
5.26
Volume
68
0.00 Day's Range 0.00
4.275 52 Week Range 11.555
Market Cap
Previous Close
5.22
Open
-
Last Trade
50
@
5.26
Last Trade Time
00:32:54
Financial Volume
-
VWAP
-
Average Volume (3m)
1,818,228
Shares Outstanding
252,527,585
Dividend Yield
-
PE Ratio
-11.07
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$5.22. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.275 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares in issue. The market capitalisation of Maravai LifeSciences is US$1.32 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -11.07.

MRVI Latest News

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...

Maravai LifeSciences plant die Übernahme des DNA- und RNA-Geschäfts von Officinae Bio und fördert damit die Unterstützung innovativer Nukleinsäureforschung

Durchbrüche von Officinae Bio bei KI-gestützten Methoden zur Nukleinsäureherstellung zur Verbesserung der mRNA-Herstellungskapazitäten von Maravai innerhalb des TriLink...

Maravai LifeSciences prévoit d’acquérir les activités ADN et ARN d’Officinae Bio afin de renforcer son soutien à la recherche innovante sur les acides nucléiques

Les percées d’Officinae Bio dans les méthodologies de fabrication d’acides nucléiques basées sur l’IA vont renforcer les capacités de fabrication d’ARNm de Maravai au sein de l’entreprise TriLink...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-2.429906542065.355.3654.27522359374.65686071CS
4-2.11-28.78581173267.338.174.27525129265.81412866CS
12-4.05-43.68932038839.279.64.27518182287.13179633CS
26-5.67-52.066115702510.8911.49994.27520003067.97929946CS
520.234.609218436874.9911.5554.27521870727.63033199CS
156-32.23-86.061415220337.4546.294.275206679515.14448158CS
260-25.89-83.220829315331.1163.554.275191990619.72872611CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTXRCitius Pharmaceuticals Inc
US$ 0.229
(71.15%)
27.41M
QMMMQMMM Holdings Limited
US$ 1.26
(68.02%)
31.18M
WLDSWearable Devices Ltd
US$ 2.99
(59.04%)
18.88M
ANLAdlai Nortye Ltd
US$ 3.90
(48.29%)
13
RGTIRigetti Computing Inc
US$ 2.46
(41.38%)
46.91M
SAVACassava Sciences Inc
US$ 3.64
(-86.25%)
10.86M
DALNDallasNews Corporation
US$ 4.01
(-30.38%)
42
ONCTOncternal Therapeutics Inc
US$ 0.80
(-29.82%)
122.36k
CMAXCareMax Inc
US$ 0.5245
(-27.15%)
1.27M
HSTMHealthStream Inc
US$ 25.12
(-21.96%)
10
RGTIRigetti Computing Inc
US$ 2.46
(41.38%)
46.91M
ELABElevai Labs Inc
US$ 0.0167
(-16.92%)
34.24M
CGTXCognition Therapeutics Inc
US$ 0.5102
(19.29%)
33.35M
QMMMQMMM Holdings Limited
US$ 1.26
(68.02%)
31.18M
CTXRCitius Pharmaceuticals Inc
US$ 0.229
(71.15%)
27.41M

MRVI Discussion

View Posts
Monksdream Monksdream 9 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 9 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock